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Mammalian and fungal prions arise de novo; however, the mechanism is poorly understood
in molecular terms. One strong possibility is that oxidative damage to the non-prion form of a
protein may be an important trigger influencing the formation of its heritable prion conforma-
tion. We have examined the oxidative stress-induced formation of the yeast [PSI+] prion,
which is the altered conformation of the Sup35 translation termination factor. We used tan-
dem affinity purification (TAP) and mass spectrometry to identify the proteins which associ-
ate with Sup35 in a tsa1 tsa2 antioxidant mutant to address the mechanism by which Sup35
forms the [PSI+] prion during oxidative stress conditions. This analysis identified several
components of the cortical actin cytoskeleton including the Abp1 actin nucleation promoting
factor, and we show that deletion of the ABP1 gene abrogates oxidant-induced [PSI+] prion
formation. The frequency of spontaneous [PSI+] prion formation can be increased by over-
expression of Sup35 since the excess Sup35 increases the probability of forming prion
seeds. In contrast to oxidant-induced [PSI+] prion formation, overexpression-induced [PSI+]
prion formation was only modestly affected in an abp1 mutant. Furthermore, treating yeast
cells with latrunculin A to disrupt the formation of actin cables and patches abrogated oxi-
dant-induced, but not overexpression-induced [PSI+] prion formation, suggesting a mecha-
nistic difference in prion formation. [PIN+], the prion form of Rnq1, localizes to the IPOD
(insoluble protein deposit) and is thought to influence the aggregation of other proteins. We
show Sup35 becomes oxidized and aggregates during oxidative stress conditions, but does
not co-localize with Rnq1 in an abp1 mutant which may account for the reduced frequency
of [PSI+] prion formation.
Author summary
Prions are infectious agents which are composed of misfolded proteins and have been
implicated in progressive neurodegenerative diseases such as Creutzfeldt Jakob Disease
(CJD). Most prion diseases occur sporadically and are then propagated in a protein-only
mechanism via induced protein misfolding. Little is currently known regarding how
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normally soluble proteins spontaneously form their prion forms. Previous studies have
implicated oxidative damage of the non-prion form of some proteins as an important trig-
ger for the formation of their heritable prion conformation. Using a yeast prion model we
found that the cortical actin cytoskeleton is required for the transition of an oxidized pro-
tein to its heritable infectious conformation. In mutants which disrupt the cortical actin
cytoskeleton, the oxidized protein aggregates, but does not localize to its normal amyloid
deposition site, termed the IPOD. The IPOD serves as a site where prion proteins undergo
fragmentation and seeding and we show that preventing actin-mediated localization to
this site prevents both spontaneous and oxidant-induced prion formation.
Introduction
Prions are infectious agents composed of misfolded proteins. They are associated with a group
of neurodegenerative diseases in animals and humans that have common pathological hall-
marks, typified by human Creutzfeldt-Jakob Disease (CJD). The presence of the misfolded
prion protein (PrPSc) underlies the development of prion diseases in a mechanism which
involves conversion of the normal prion protein (PrP) into its infectious PrPSc conformation
[1, 2]. Aggregated, protease-resistant PrPSc seeds are believed to act as templates that promote
the conversion of normal PrPC to the pathological PrPSc form, which is rich in Č-sheets and
resistant to chemical and enzymatic degradation. PrPc can adopt an alternative conformational
state by spontaneous misfolding event(s) that might be triggered by mutation, mistranslation,
environmental stresses and/or by disruption of the chaperone network [3].
This ‘protein-only’ mechanism of infectivity also explains the unusual genetic behaviour of
several prions found in the yeast Saccharomyces cerevisiae [4–8]. At present, several yeast pro-
teins are known to form prions with many other proteins classified as potential prion candi-
dates [9]. Additionally, the [Het-s] prion that controls vegetative incompatibility has been
described in Podospora anserina, an unrelated fungal species [10]. [PIN+] and [PSI+] are the
best studied yeast prions, which are formed from the Rnq1 and Sup35 proteins, respectively [4,
11, 12]. Sup35 is the yeast eERF3 which functions in translation termination and hence [PSI+]
formation influences the recognition of translation stop codons. [PSI+] formation requires the
presence of an another prion, termed [PIN+], which is often present as the prion form the
Rnq1 protein whose native protein function is unknown [13–15]. However, a number of pri-
ons can be designated as [PIN+] that are required for the de novo formation of [PSI+] [16–18].
Several studies have demonstrated the infectious behavior of the fungal prion associated with a
particular phenotype adding further weight to the ‘protein-only’ mechanism of prion propaga-
tion [19–21],
How prions form spontaneously without underlying infection or genetic change is poorly
understood at the molecular level, yet if we are to develop effective preventative measures for
human and animal amyloidoses, this mechanism must be established. Of particular importance
is identifying what can trigger this event. Several different environmental stress conditions,
including heat, oxidative and salt stresses, increase the frequency of yeast [PSI+] prion formation
[22]. A number of mutants have been identified which increase the frequency of [PSI+] forma-
tion [22]. This includes a number of mutations in the protein homeostasis network including
mutations in chaperones and the autophagy system [7, 23]. Additionally, formation of the yeast
[GAR+] prion can be induced by bacterial exposure in a chemical induction mechanism and the
[GAR+] prion can be lost upon desiccation [24–26]. The spontaneous formation of prions may
Induction of yeast prions by reactive oxygen species
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therefore occur as a result of random protein misfolding events which are normally dealt with
by the cellular protein quality control systems.
One strong possibility underlying the de novo formation of prions is that oxidative damage
to the non-prion form of a protein may be an important trigger influencing the formation of
its heritable prion conformation [27]. For example, methionine oxidation of mammalian PrP
has been proposed to underlie the misfolding events which promote the conversion to PrPSc
[28–30] while methionine oxidation destabilizes native PrP facilitating misfolding and transi-
tion to the PrPSc conformation [31]. Methionine oxidation is also a common factor in many
protein misfolding diseases [32–34] and an age-dependent increase in methionine oxidation
has been detected in various model systems [35]. Oxidative stress has been shown to increase
the frequency of yeast [PSI+] prion formation [22]. The de novo formation of the [PSI+] prion
is also significantly increased in yeast mutants lacking key antioxidants suggesting that endog-
enous reactive oxygen species (ROS) can trigger the de novo formation of the [PSI+] prion [36–
38]. Preventing methionine oxidation by overexpressing methionine sulphoxide reductase
abrogates the shift to the prion form indicating that the direct oxidation of Sup35 may trigger
structural transitions favouring its conversion to the transmissible amyloid-like form [37, 38].
Hence, protein oxidation may be a common mechanism underlying the aggregation of some
mammalian and some yeast amyloid-forming proteins.
The frequency of de novo appearance of the [PSI+] prion is increased by overexpression of
Sup35 in [PIN+][psi-] which increases the probability of forming prion seeds [4]. This fre-
quency can be influenced by components of the actin cytoskeleton which physically associate
with Sup35 including various proteins of the cortical actin cytoskeleton (Sla1, Sla2, End3,
Arp2, Arp3) that are involved in endocytosis [39]. Loss of some of these proteins decreases the
aggregation of overexpressed Sup35 and de novo [PSI+] formation. This is particularly interest-
ing given the increasing evidence suggesting that cytoskeletal structures provide a scaffold for
the generation of protein aggregates. Insoluble aggregates of amyloid-forming proteins includ-
ing prions are targeted to the IPOD as part of the cells’ protein quality control system [40, 41].
The IPOD is located at a perivacuolar site adjacent to the preautophagosomal structure (PAS)
where cells initiate autophagy [42]. Prion conversion has been proposed to occur at the cell
periphery in association with the actin cytoskeleton, prior to deposition at the IPOD [43]. The
actin cytoskeleton has also been implicated in the asymmetric inheritance of oxidatively-dam-
aged proteins [44]. Actin organization therefore appears to play an important role in the aggre-
gation of damaged proteins, which can result in prion formation.
Oxidative stress provides a powerful tool to examine the de novo formation of prions since
it does not necessitate overexpression or mutation of the normally soluble version of the prion
protein. In this current study, we have used a mutant lacking the Tsa1 and Tsa2 antioxidants
to isolate the proteins which aggregate with Sup35. We used a tsa1 tsa2 antioxidant mutant to
enrich for factors which associate with oxidized Sup35 and therefore might be important for
the conversion of Sup35 to the [PSI+] prion. Our data suggest a key role for the cortical actin
cytoskeleton since we identified a number of components of the Arp2/3 actin-nucleation com-
plex which specifically associate with Sup35 in the antioxidant mutant. We show that loss of
several of these factors abrogates the increased frequency of [PSI+] prion formation which is
normally observed in response to oxidative stress conditions. However, these mutants do not
affect the increased frequency of [PSI+] prion formation induced in response to Sup35 overex-
pression. We show that Sup35 oxidative damage and aggregation occurs in actin-nucleation
complex mutants in response to oxidative stress conditions, but the aggregates do not appear
to form normally at the IPOD. Our data suggest that the cortical actin cytoskeleton is impor-
tant for the formation of a propagating [PSI+] conformer following oxidant-induced misfold-
ing and aggregation of Sup35.
Induction of yeast prions by reactive oxygen species
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Results
Identification of Sup35-interacting proteins in a tsa1 tsa2 mutant
To address the mechanism by which Sup35 forms the [PSI+] prion during oxidative stress con-
ditions, we used tandem affinity purification (TAP) and mass spectrometry to identify proteins
which associate with Sup35 in a tsa1 tsa2mutant. For this analysis, we used [PIN+][psi-] ver-
sions of wild-type and tsa1 tsa2mutant strains containing genomically-tagged Sup35. We have
previously confirmed that TAP-tagging Sup35 does not affect reversible [PSI+] prion forma-
tion [37]. Freshly inoculated strains were grown for 20 hours (approximately ten generations)
and Sup35 affinity-purified from both strains using TAP chromatography. The associated pro-
teins were identified from three repeat experiments and were considered significant if they
were identified in at least two independent experiments. This resulted in the identification of
63 and 47 proteins which co-purify with Sup35 in the wild-type and tsa1 tsa2mutant strains,
respectively (S1 Table).
We searched for functional categories that were enriched in the Sup35 co-purifying pro-
teins using MIPS category classifications (Fig 1A and S2 Table). The overlap between the wild
type and tsa1 tsa2 datasets is 18 proteins and, as might be expected, this included functions
related to protein fate (>3-fold enrichment; Fischer’s exact test, P<10−7) such as chaperones
and stress-related proteins (Sti1, Sse1, Cdc48, Ssa2, Hsc82, Ssb2, Ssa1, Hsp60) many of which
have well characterized roles in prion formation and propagation in yeast [5]. Similar func-
tional proteins were identified as part the unfolded protein response (21-fold; P = 1.5×10−8)
and stress response categories (4-fold; P = 2×10−5). Over represented functions in the wild-
type strain included protein synthesis (2-fold; P = 2×10−5) and protein folding and stabilization
(9-fold; P = 2×10−10). The protein synthesis category included a number of ribosomal proteins
and translation factors which might be expected to associate with the Sup35 translation termi-
nation factor. Interestingly, proteins associated with the actin cytoskeleton were overrepre-
sented in the tsa1 tsa2mutant (8-fold; P = 4×10−6), but not in the wild-type strain and were
therefore subject to further analysis.
Our data suggest an important role for the cortical actin cytoskeleton based on the cytoskel-
eton-related proteins which co-purify with Sup35 in the tsa1 tsa2mutant strain (Act1, Sac6,
Crn1, Abp1, Arc40, Arp2, Arp3 and Arc35). These data strongly implicate the Arp2/3 com-
plex, which is a seven-protein complex containing two actin-related proteins (Arp2 and Arp3)
and five non-actin related proteins including Arc35 and Arc40 [45]. Abp1 is an actin-binding
protein of the cortical actin cytoskeleton which is important for activation of the Arp2/3 com-
plex [46]. Crn1 and Act1 were identified with purified Sup35 in both the wild-type and tsa1
tsa2mutant strains. Crn1 is an actin-binding protein which regulates the actin filament nucle-
ation and branching activity of the Arp2/3 complex through its interaction with the Arc35
subunit [47]. Act1 is encoded by ACT1, a single essential gene in yeast. We validated our
Sup35-interacting proteins for a number of proteins. Sup35-TAP was immunoprecipitated
from the wild-type and tsa1 tsa2mutant and possible interactions examined using Western
blot analysis (Fig 1B). This analysis confirmed that Abp1, Arp3 and Sap190 co-purify with
Sup35 in the tsa1 tsa2mutant strain and Act1 co-purifies with Sup35 in both the wild-type and
tsa1 tsa2mutant strains.
Mutations disrupting the cortical actin cytoskeleton abrogate oxidative
stress-induced prion formation
In order to test whether the Sup35-associated proteins affect oxidative stress-induced prion
formation, mutant strains were constructed in a [PIN+][psi-] yeast strain (74D-694) which is
Induction of yeast prions by reactive oxygen species
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commonly used to study yeast prion biology. We were unable to make arp2, arp3, arc35 or
arc40 deletion mutants in this strain background in agreement with previous observations sug-
gesting that components of the Arp2/Arp3 complex are essential for normal growth and viabil-
ity [39, 48, 49]. We therefore focused on Abp1 and Crn1, which were identified in our Sup35
immunopurification experiments. The induction of [PSI+] prion formation was quantified by
analysing the formation of Ade+ colonies which arise due to nonsense suppression of the
ade1-14mutant allele. [PSI+]-mediated suppression can be differentiated from nuclear-
encoded nonsense suppressor mutations by their elimination in guanidine hydrochloride
(GdnHCl). The control [PIN+][psi-] strain was grown in the presence of 100 μM hydrogen per-
oxide for 20 hours prior to scoring [PSI+] prion formation. This oxidative stress treatment
increased the frequency of [PSI+] prion formation by approximately ten-fold (Fig 2A), similar
to our previous observations [38]. The basal frequency of spontaneous [PSI+] prion formation
was reduced by approximately 150-fold in the abp1 mutant and 30-fold in the crn1mutant.
Furthermore, loss of ABP1 or CRN1 abrogated the peroxide-induced increase in [PSI+] prion
Fig 1. Identification of Sup35-interacting proteins in wild-type and tsa1 tsa2 mutant strains. A. Functional categorisation of Sup35-associated
proteins. Results are ordered on MIPS category classification numbers and overarching categories are in capitals. Where an overarching category was
enriched, sub-categories within the overarching category were omitted from the graph. Confidence of each classification category is shown as Bonferroni
corrected p-values. B. Sup35-TAP was immunoprecipitated from the wild-type and tsa1 tsa2 mutant and possible interactions examined using immuno-blot
analysis with the indicated antibodies. Sup35-TAP co-immunoprecipitates Abp1, Arp3 and Sap190 in a tsa1 tsa2 mutant. Sup35-TAP co-immunoprecipitates
Act1 in both wild-type and tsa1 tsa2 mutant strains. Total denotes whole cell extracts and IP denotes immunoprecipitates.
https://doi.org/10.1371/journal.pgen.1006708.g001
Induction of yeast prions by reactive oxygen species
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Fig 2. Reduced frequency of [PSI+] formation in cortical actin cytoskeleton mutants. A. The frequency of de novo [PSI+] prion formation was
quantified in wild-type abp1, crn1, and pan1 mutant strains grown in the presence or absence of 100ȝM hydrogen peroxide for 20 hours. [PSI+]
formation was quantified using the ade1-14 mutant allele by growth on media lacking adenine and differentiated from nuclear gene mutations by their
irreversible elimination in GdnHCL. Data shown are the means of at least three independent biological repeat experiments expressed as the number of
colonies per 105 viable cells. Error bars denote standard deviation; * marks statistical significance at p0.01. B. [PSI+] propagation was scored by
culturing [PSI+]-versions of wild-type and abp1 mutant strains for four days. [PSI+] maintenance was quantified using the ade1-14 mutant allele as
above and is expressed as the percentage of [PSI+] cells from three independent biological repeat experiments. C. The frequency of de novo [PSI+]
prion formation was quantified in wild-type, tsa1 tsa2 and tsa1 tsa2 abp1 mutants. Error bars denote standard deviation; * marks statistical significance
at p0.01. D. De novo [PIN+] prion formation was quantified in the wild-type and abp1 mutant strain grown in the presence or absence of 100ȝM
hydrogen peroxide for 20 hours. Data shown are the means of three independent biological repeats expressed as the percentage of viable cells
forming [PIN+] colonies. Error bars denote standard deviation (*p0.01; # p0.05).
https://doi.org/10.1371/journal.pgen.1006708.g002
Induction of yeast prions by reactive oxygen species
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1006708 April 3, 2017 6 / 23
formation (Fig 2A). The nucleation of actin patches by the Arp2/3 complex is enhanced by the
activity of nucleation promoting factors such as Abp1 [45, 50–52]. We therefore tested whether
loss of another nucleation promoting factor, Pan1, similarly reduced the frequency of [PSI+]
prion formation. The frequency of spontaneous [PSI+] prion formation was significantly
reduced in the pan1 mutant and no induction was observed in response to hydrogen peroxide
stress (Fig 2A). We ruled out any effects on [PSI+] propagation by following [PSI+]-mainte-
nance in [PSI+] versions of wild-type and abp1 mutant strains. After four days of culture, the
formation of [psi-] cells was comparable in the wild-type and abp1 mutant strains (Fig 2B).
Since our Sup35-interacting proteins were identified in a tsa1 tsa2mutant, we examined
whether deletion of ABP1 affects the high frequency of spontaneous [PSI+] formation normally
observed in a tsa1 tsa2mutant [36]. The frequency of [PSI+] formation was increased approxi-
mately 30-fold in a tsa1 tsa2mutant compared with the wild-type strain (Fig 2C). [PSI+] for-
mation was significantly decreased in a tsa1 tsa2 abp1 mutant suggesting that Abp1 is required
for the elevated frequency of [PSI+] formation in a tsa1 tsa2mutant.
Since mutations which disrupt the cortical actin cytoskeleton reduce oxidative stress
induced [PSI+] formation, we next examined whether the formation of another prion unre-
lated in sequence to the Sup35/[PSI+] prion, is similarly affected. Rnq1 can switch to the
[PIN+] prion, which is formed at relatively high frequencies compared with the de novo forma-
tion of [PSI+] [53, 54]. The de novo formation of [PIN+] prions, which is also dependent on
oxidative status of the cells [37], was detected in approximately 6% of control [pin-] cells, com-
pared with 1.7% of abp1 mutant cells (Fig 2D). Hydrogen peroxide treatment increased the fre-
quency of [PIN+] prion formation in both strains, but the frequency of [PIN+] formation was
significantly lower in the abp1 mutant compared with the wild-type strain. Loss of ABP1 there-
fore appears to decrease the spontaneous formation of both the [PSI+] and [PIN+] prions, but
has a greater effect on the oxidative stress induced formation of [PSI+] compared with [PIN+].
Loss of ABP1, CRN1 or PAN1 does not significantly alter the frequency
of overexpression-induced [PSI+] prion formation
[PSI+] prion formation can be induced by the overexpression of Sup35 in [PIN+] [psi-] strains
due to the increased possibility for prion seed formation [4]. We therefore tested whether loss
of ABP1, CRN1 or PAN1 similarly affected the frequency of overexpression-induced [PSI+]
prion formation. SUP35NM-GFPwas induced for 24 hours and visible fluorescent aggregates
were observed in 6.1% of wild-type cells examined (Fig 3A). This included large fluorescent
foci which arise due to decorating existing aggregates (3.7%), as well as rod- and ribbon-like
aggregates (2.4%) characteristic of the de novo formation of [PSI+] [39, 43, 55]. Loss of CRN1
or PAN1 resulted in modest decreases in Sup35 aggregation including the formation of fewer
visible puncta and rod and ribbon-like aggregates (Fig 3A). A stronger effect was seen with the
abp1 mutant, with no rod or ribbon-like aggregates detected, although 1% of abp1 mutant cells
still contained visible SUP35NM-GFP puncta (Fig 3A). As a control, Western blot analysis was
used to confirm that similar levels of Sup35NM-GFP were induced in the wild-type, abp1, crn1
and pan1 mutant strains (Fig 3B).
Rhodamine-phalloidin staining was used to visualize the cortical actin cytoskeleton in the
wild-type and mutant strains. Multiple bright rhodamine-phalloidin–stained puncta were
detected in the wild-type strain (S1 Fig), typical of the cortical actin patches normally observed
in wild-type yeast cells [56, 57]. In comparison, fewer, fainter cortical actin patches were
detected in the abp1 and crn1mutant strains, and fewer brighter patches were detected in pan1
mutant cells. In some cells, the formation of Sup35NM-GFP aggregates was coincident with
actin patches but this was difficult to differentiate since rhodamine-phalloidin–stained puncta
Induction of yeast prions by reactive oxygen species
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covered a large proportion of the cellular cortex (S1 Fig). This is similar to previous studies
which have shown that few Sup35-GFP puncta [39] or no Sup35-GFP puncta [55] co-localize
with actin patches. Similarly some examples of co-localized Sup35NM-GFP/rhodamine-phal-
loidin–stained puncta were observed in the abp1, crn1 and pan1 mutants. Although it is diffi-
cult to determine whether Sup35 aggregates are associated with the cortical actin cytoskeleton,
our mutants which disrupt cortical actin patch formation do not appear to significantly affect
overexpression-induced Sup35 aggregate formation.
The presence of fluorescent SUP35-GFP aggregates is not necessarily indicative of [PSI+]
prion formation since some cells with fluorescent dots will die, and some contain non-produc-
tive or non-amyloid aggregates [58]. We therefore quantified [PSI+] prion formation using the
Fig 3. Induction of [PSI+] prion formation by overexpression of Sup35. A. Fluorescence micrographs are shown for [PIN+][psi-] versions of wild-type,
abp1, crn1 and pan1 mutant strains containing the Sup35NM-GFP plasmid induced with copper for 24 hours. Representative Images are shown for rod/
ribbon-like and foci aggregate formation. The numbers indicate the percentage of cells containing each type of aggregate from an average of 300 cells
counted. The scale bar is 3ȝm. B. Western blot analysis of the wild-type and abp1 mutant strain following induction of Sup35NM-GFP. Blots were probed
with ĮSup35 or Į-Pgk1 as a loading control (C) [PSI+] prion formation was quantified in the wild-type and abp1 mutant strain containing the Sup35NM-GFP
plasmid following 24 h of copper induction. Data shown are the means of three independent biological repeat experiments expressed as the number of
colonies per 104 viable cells. Error bars denote standard deviation; * marks statistical significance at p0.01.
https://doi.org/10.1371/journal.pgen.1006708.g003
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ade1-14mutant allele as described above. [PSI+] formation was strongly induced by approxi-
mately 65-fold in the wild-type [PIN+][psi-] strain in response to Sup35 overexpression (Fig
3C). A similar induction of [PSI+] prion formation was observed in the crn1 and pan1 mutants.
This induction was reduced in the abp1 mutant compared with the wild-type strain, although
a 21-fold increase in the frequency of [PSI+] prion formation was still observed in response to
Sup35 overexpression (Fig 3C). Taken together, these data indicate that in contrast to oxidative
stress-induced prion formation, mutations which disrupt cortical actin patch formation only
modestly affect the induction of [PSI+] prion formation in response to Sup35 overexpression.
Latrunculin A treatment disrupts oxidative stress-induced [PSI+] prion
formation
Treatment of yeast cells with latrunculin A (LTA) disrupts the formation of actin cables and
patches [59]. This has been used to show that the actin cytoskeleton plays a role in [PSI+] prop-
agation since disrupting the actin cytoskeleton by treatment with LTA causes the loss of [PSI+]
from yeast cells [60]. This effect was observed at relatively high concentrations of LTA (40–
200 μM) and so we wanted to test whether a lower concentration of LTA, which does not sig-
nificantly affect [PSI+] propagation, might disrupt oxidative-stress induced prion formation.
We first tested the effect of growing a [PSI+] strain in the presence of 10 μMLTA for 20 hours.
This concentration of LTA resulted in modest curing (9.3 ± 0.3%) of [PSI+] and so we reasoned
that we could use this concentration of LTA to test whether it affects the induction of [PSI+].
Rhodamine-phalloidin staining was used to visualize the cortical actin cytoskeleton and to
confirm that the 10 μM LTA treatment disrupted the formation of actin patches (Fig 4A).
The wild-type [PIN+][psi-]-strain was grown in the presence of 10 μM LTA and 100 μM
hydrogen peroxide for 20 hours to induce prion formation. We first examined Sup35 puncta
formation by expressing SUP35NM-GFP for the final two hours of the oxidant treatment.
Approximately 8% of wild-type cells contained visible Sup35 aggregates following exposure to
hydrogen peroxide. This frequency was somewhat reduced in cells treated with 10 μM LTA,
where 3.9% of cells examined contained visible Sup35 aggregates (Fig 4B). [PSI+] prion forma-
tion was quantified under the same conditions, using the ade1-14-based assay. LTA treatment
decreased the basal frequency of [PSI+] prion formation by 3-fold and also abrogated the oxi-
dant-induced increase in the frequency of [PSI+] prion formation (Fig 4C). For comparison,
we examined whether a 10 μM LTA treatment affected overexpression-induced [PSI+] prion
formation. [PSI+] formation was strongly induced in response to Sup35 overexpression and
only a modest decrease in induction frequency was observed in the presence of LTA (Fig 4D).
Western blot analysis was used to confirm that LTA does not affect Sup35 overexpression (Fig
4E). Thus, LTA strongly disrupts oxidant-induced [PSI+] prion formation, but only modestly
affects overexpression-induced [PSI+] prion formation.
Analysis of Sup35 oxidation and protein aggregation in abp1 mutant
cells
Disrupting the actin cytoskeleton may potentially decrease oxidative stress-induced [PSI+]
prion formation in a number of different ways including preventing Sup35 oxidative damage,
altering the formation of Sup35 protein aggregates or by disrupting the formation of heritable
[PSI+] propagons. We have previously shown that Sup35 oxidative protein damage is an
important trigger for the formation of the heritable [PSI+] prion in yeast [37, 38]. We therefore
examined the extent of Sup35 oxidative damage in response to oxidative stress conditions, to
determine whether disrupting the cortical actin cytoskeleton influences protein oxidative dam-
age. Protein carbonylation is a commonly used measure of protein oxidative damage [61].
Induction of yeast prions by reactive oxygen species
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Fig 4. Latrunculin A treatment reduces oxidant-induced [PSI+] formation. A. Representative fluorescence micrographs are shown for a [PIN+]
[psi-] strain treated with 10 ȝM LTA for 20 hours. Cells were fixed, and stained with rhodamine phalloidin to visualize the cortical actin cytoskeleton.
B. Fluorescence micrographs are shown for a [PIN+][psi-] strain treated with 100 ȝM hydrogen peroxide for 20 hours in the presence or absence of
10 ȝM LTA. The aggregate frequency is shown as the percentage of cells containing visible Sup35 foci from approximately 1000 cells counted. Error
bars denote standard deviation; * marks statistical significance at p0.01. C. [PSI+] prion formation was quantified in a [PIN+][psi-] strain treated with
100ȝM hydrogen peroxide for 20 hours in the presence or absence of 10 ȝM LTA. Data shown are the means of three independent biological
repeats expressed as the number of [PSI+] colonies per 105 viable cells. Error bars denote standard deviation; * marks statistical significance at
p0.01. (D) [PSI+] prion formation was quantified in a [PIN+][psi-] strain containing the Sup35NM-GFP plasmid following 1 and 24 h of copper
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Carbonyl groups on proteins can be detected by Western blot analysis using an antibody
against the carbonyl-specific probe DNPH. Using this assay we found that oxidative stress
increased Sup35-carbonylation in response to oxidative stress as might be expected (Fig 5A). A
similar increase in carbonylation was detected in the wild-type, abp1, crn1 and pan1 mutant
strains suggesting that Sup35 protein oxidative damage is not altered in the mutant strains.
To address whether disrupting cortical actin patch formation influences Sup35 aggregate
formation, the subcellular distribution of Sup35 was examined biochemically during oxidative
stress conditions. We used a protocol which separates soluble fractions from SDS-insoluble
high-molecular weight forms [62]. Sup35 was predominantly detected in the soluble fraction
in wild-type cells as expected. In response to oxidative stress conditions, a small fraction of
Sup35 was present in an SDS-insoluble high-molecular weight form (Fig 5B). Surprisingly, a
significant proportion of Sup35 was already present in this SDS-insoluble high-molecular
weight form in the abp1 mutant in the absence of stress, and there was no further increase in
response to hydrogen peroxide treatment (Fig 5B). This suggests that Sup35 aggregates in an
abp1 mutant but is not converted to the heritable [PSI+] prion form.
For comparison to Sup35 aggregation, we next examined the aggregation of a non-amyloi-
dogenic protein in the abp1 mutant. We used a thermolabile allele of UBC9 fused to GFP
(GFP–Ubc9ts) which was expressed under the control of the GAL1 galactose-regulated pro-
moter [63]. At permissive temperatures, GFP–Ubc9ts is native and diffuse, whereas, shifting
cells to 37˚C causes GFP–Ubc9ts to misfold and to form puncta visible by fluorescence micros-
copy. These protein quality control structures are referred to as Q-bodies and do not contain
amyloid aggregates [63]. Cells were grown in raffinose medium prior to inducing GFP–Ubc9ts
expression for three hours following galactose addition. We found that approximately 90% of
wild-type cells formed Q-bodies following a temperature shift to 37˚C for 30 minutes (Fig 5C).
A similar number of cells containing Q-bodies were also detected in the abp1 mutant suggest-
ing that loss of ABP1 does not affect non-amyloidogenic protein aggregation.
Loss of ABP1 reduces the co-localization of Sup35 with Rnq1 puncta
Given that Sup35 is oxidized and aggregates in an abp1 mutant strain we assessed the intracel-
lular localization of Sup35 in an abp1 mutant. We first quantified Sup35 puncta formation
using the SUP35NM-GFP fusion to visualize aggregate formation. The wild-type and abp1
mutant strains were treated with 100μM hydrogen peroxide for 20 hours and SUP35NM-GFP
expression induced for the final two hours by copper addition. Following hydrogen peroxide
treatment, approximately 6% of wild-type cells contained visible Sup35 aggregates (Fig 6A).
This was reduced in abp1 mutant cells where 0.5% of cells examined contained visible Sup35
aggregates.
The amyloidogenic [PIN+] prion form of Rnq1 localizes to the IPOD and is thought to
influence the aggregation of other proteins [41, 64]. This is further supported by the observa-
tion that during overexpression induced [PSI+] prion formation, approximately 60% of
Sup35-RFP puncta co-localize with Rnq1-GFP puncta [58]. Newly formed Sup35-RFP puncta
were found to perfectly co-localize with Rnq1-GFP puncta, whereas, mature Rnq1-GFP and
Sup35-RFP puncta were found that did not co-localize. We therefore visualized the relation-
ship of Sup35 and Rnq1 during oxidant-induced [PSI+] prion formation. [PIN+][psi-]-versions
of the wild-type and abp1 mutant strains were grown in the presence of 100 μM hydrogen
induction in the presence or absence of 10 ȝM LTA. Data shown are the means of three independent biological repeats expressed as the number of
[PSI+] colonies per 104 viable cells. Error bars denote standard deviation; * marks statistical significance at p0.01. E. Western blot analysis of cells
grown under the same conditions as for panel D. Blots were probed with Į-Sup35 and Į-Pgk1 as a loading control.
https://doi.org/10.1371/journal.pgen.1006708.g004
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peroxide for 20 hours to induce prion formation. Sup35NM-RFP and Rnq1-GFP were
expressed under the control of the GAL1 promoter and were induced for three hours to visual-
ize Sup35 and Rnq1 aggregate formation. Similar to overexpression-induced [PSI+] prion for-
mation, 76% of Sup35 puncta co-localized with Rnq1 puncta following oxidant treatment of
Fig 5. Analysis of protein oxidation and aggregation in an abp1 mutant. A. Mutants disrupting the
cortical actin cytoskeleton dot not affect Sup35 protein oxidative damage. The wild-type, abp1, crn1 and pan1
mutant strains were treated with 100ȝM hydrogen peroxide for 20 hours and protein carbonylation used as a
measure of protein oxidative damage. Protein extracts were treated with the carbonyl-specific probe, DNPH,
and analyzed by Western blot analysis using an antibody against DNPH. B. Subcellular distribution of Sup35
in wild-type and abp1 mutant cells grown in the presence or absence of 100ȝM hydrogen peroxide for 20
hours. Total denotes total crude extract; Soluble, soluble fraction; Pellet, SDS-resistant high molecular weight
fraction. C. Representative fluorescent micrographs are shown for wild-type and abp1 mutant cells expressing
GFP–Ubc9ts. Strains were grown in SRaf media before switching to SGal media to induce GFP–Ubc9ts
expression for 3 hours. This was followed by a 37˚C heat shock for 30 minutes to trigger the misfolding and
aggregation of Ubc9. Quantification of the frequency of GFP–Ubc9 foci is expressed as the percentage of
cells containing fluorescence foci out of approximately 300 cells counted. Error bars denote standard
deviation.
https://doi.org/10.1371/journal.pgen.1006708.g005
Induction of yeast prions by reactive oxygen species
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1006708 April 3, 2017 12 / 23
Fig 6. Loss of ABP1 reduces the co-localization of Sup35 with Rnq1 aggregates. A. Fluorescence micrographs are shown for the wild-
type and abp1 mutant strain treated with 100 ȝM hydrogen peroxide for 20 hours. Sup35-NMGFP was induced with copper for 2 hours to
visualize aggregate formation and the frequency is shown as the percentage of cells containing visible Sup35 foci from approximately 1000
cells counted. Error bars denote standard deviation; * marks statistical significance at p0.01. B. The wild-type and abp1 mutant strains
containing Sup35NM-RFP and Rnq1-GFP were grown for 20 hours in SRaff media in the presence or absence of 100ȝM hydrogen peroxide
before switching to SGal media for three hours to induce the expression of Sup35NM-RFP and Rnq1-GFP. White arrows show examples
where Sup35NM-RFP and Rnq1-GFP co-localize, whereas, grey arrows show examples where Sup35NM-RFP does not localize with
Rnq1-GFP. The frequency of co-localization of Sup35NM-RFP and Rnq1-GFP is shown as a percentage of co-localization for at least 17
Sup35NM-RFP foci scored in triplicate experiments. * marks statistical significance at p0.01
https://doi.org/10.1371/journal.pgen.1006708.g006
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the wild-type strain (Fig 6B). In contrast, 17% of Sup35 puncta co-localized with Rnq1 puncta
following oxidative stress conditions in the abp1 mutant strain. We also searched for rare
Sup35 puncta formation in the absence of stress conditions and found a similar result where
71% of Sup35 puncta colocalized with Rnq1 puncta in a wild-type strain, compared with just
13% co-localization the abp1 mutant strain.
Discussion
Our data suggest an important role for the Arp2/3 complex in prion formation since deletion
of the ABP1, CRN1 or PAN1 genes abrogate oxidant-induced [PSI+] prion formation (Fig 2A
and 2B). The Arp2/3 complex contains two actin-elated proteins (Arp2 and Arp3) and five
non-actin related proteins [45]. It is required for the motility and integrity of actin cortical
patches, and for actin-dependent processes such as endocytosis and organelle inheritance. For
example, conditional Arp2/3 mutants are deficient in actin patch formation suggesting that
Arp2/3 is required for the assembly and organization of cortical actin filaments [65]. Nucle-
ation-promoting factors such as Abp1 and Pan1 associate with the Arp2/3 complex and stimu-
late actin nucleation [50, 52]. Crn1 regulates actin filament nucleation and the branching
activity of the Arp2/3 complex through its interaction with the Arc35 subunit [47]. We found
that disrupting the actin cytoskeleton by deletion of ABP1, or treating cells with LTA, decreased
the frequency of [PSI+] prion formation during oxidative stress conditions (Figs 2A, 2B and
4C). This suggests that the cortical actin cytoskeleton is required for the conversion of oxida-
tively damaged Sup35 into its heritable prion form.
Previous studies have implicated the Arp2/3 complex in prion formation and shown that
Sup35 physically interacts with various proteins of the cortical actin cytoskeleton [39]. This
includes Arp2 and Arp3 which were shown to interact with the N-terminal prion-forming
domain of Sup35 during normal non-stress conditions using a two-hybrid assay. In contrast,
we found that Arp2 and Arp3 are enriched in the Sup35-interacting proteins identified under
oxidative stress conditions (Fig 1). This difference might arise since we have used native Sup35
expressed under the control of its own promoter, rather than a fragment of Sup35 fused to the
DNA domain of Gal4 in a two-hybrid assay. Additionally, Gal4-activation domain fusion pro-
teins are unlikely to assemble into normal actin complex structures in the nuclear two-hybrid
assay [39]. An interaction between actin and overexpressed Sup35 was also demonstrated
using immunoprecipitation experiments [39] similar to our finding that Sup35 interacts with
actin in wild-type and tsa1 tsa2mutant cells (Fig 1). We also found that Crn1 interacts with
Sup35 in both the wild-type and tsa1 tsa2mutant strains. Arp2/3 complex-related proteins
therefore appear to be common Sup35-interacting proteins, although certain components
show an increased interaction under oxidative stress conditions.
Disrupting the cortical actin cytoskeleton, either genetically by deletion of ABP1, CRN1 or
PAN1, or chemically, by treating cells with LTA, prevented oxidative stress-induced [PSI+]
prion formation. In contrast, similar disruption of the cortical actin cytoskeleton did not sig-
nificantly alter Sup35-overexpression-induced [PSI+] prion formation (Figs 3C and 4D). This
suggests that the mechanism underlying the conversion of the soluble protein to its amyloid
form is different for overexpression-induced versus oxidative stress-induced prion formation.
However, there are mechanistic similarities for these two induction pathways since cortical
actin cytoskeleton mutants do influence overexpression-induced [PSI+] prion formation. For
example, an abp1 mutant abrogated Sup35 ring formation, although the frequency of [PSI+]
prion formation was still strongly induced in this mutant. Other studies have linked cortical
actin patch formation with overexpression-induced [PSI+] prion formation. For example, loss
of LAS17 or SAC6 abrogates overexpression-induced [PSI+] prion formation [66, 67]. Las17 is
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a nucleation-promoting factor similar to Pan1 and Abp1, although Las17 is a stronger nucle-
ation-promoting factor compared with Pan1 and Abp1 [68]. Sac6, an actin-bundling protein,
is the major F-actin crosslinking protein in budding yeast [69]. Additionally, loss of other
genes affecting actin patch formation including SLA1, SLA2 and END3 decreases the frequency
of Sup35 overexpression-induced [PSI+] formation [39, 43]. Taken together, these data
strongly implicate actin cytoskeletal networks in de novo [PSI+] prion formation, although
there appear to be mechanistic differences between overexpression and oxidative stress-
induced prion formation.
Much previous research has made use of the Sup35NM-GFP fusion that we used to visual-
ize [PSI+] prion formation. As with wild-type Sup35, the Sup35NM-GFP fusion protein retains
the unstructured PrD that has a high propensity to misfold [39, 55, 58, 70]. Overexpression of
Sup35NM-GFP is frequently used to visualize [PSI+] formation since the spontaneous forma-
tion of prions is very low making it difficult to observe during normal growth conditions. Oxi-
dative stress conditions increase the frequency of [PSI+] formation making it possible to
visualize [PSI+] formation without Sup35 overexpression. We observed cells containing
puncta, which included examples of cells containing few (sometimes one) large dots and cells
containing multiple smaller dots (Fig 6). The frequency of puncta formation was reduced in
the abp1 mutant compared with a wild-type strain, although it was still significantly higher
than the frequency of [PSI+] prion formation observed in the abp1 mutant in response to the
same oxidative stress conditions. This is not surprising because Sup35-GFP puncta are not
necessarily indicative of amyloidogenic-aggregation since GFP-puncta may arise due to amor-
phous aggregation or the formation of other granules such as stress granules. In fact, cell frac-
tionation experiments revealed that Sup35 was more prevalent in an SDS-insoluble high-
molecular weight form in an abp1 mutant during both non-stress and oxidative stress condi-
tions compared with a wild-type strain (Fig 5B). Together with our observation that Sup35
protein oxidation is similar in wild-type and abp1 mutant strains (Fig 5A) it does not seem
likely that alterations in protein oxidation and aggregation account for the reduced frequency
of [PSI+] prion formation in cortical actin cytoskeleton mutants. The Arp2/3 complex may
therefore be required to provide the driving force for aggregate movement via growing actin
filament formation. In the absence of the Arp2/3 complex, Sup35 aggregates are formed but
are not transported to protein quality control compartments where prion formation occurs.
Accumulating evidence suggests that eukaryotic cells defend themselves against protein
aggregation by sequestering misfolded proteins into defined quality control compartments.
Studies in yeast cells have revealed intricate protein quality control systems where insoluble
proteins are partitioned into defined sites in the cell. Amyloid and amorphous aggregates are
believed to be processed via distinct cytosolic protein inclusion bodies [40, 41]. Upon protea-
some inhibition, JUNQ serves as a sequestration site for ubiquitinated proteins, whereas, the
IPOD sequesters terminally misfolded and amyloidogenic proteins. When proteasomes are
active, misfolded proteins aggregate into Q-bodies [63, 71, 72]. Overexpressed Sup35NM-GFP
is initially soluble, but the PrD has a high propensity to misfold and the misfolded protein is
thought to be targeted to the IPOD via Myo2-based actin cable transport [64, 73]. Other prion
proteins including Ure2 and Rnq1 localize to the IPOD which facilitates nucleation and [PSI+]
induction [41, 64]. Accordingly, following Sup35NM-GFP overexpression, most newly
induced Sup35 dots overlap with Rnq1 dots [58]. Similarly, we found that most oxidant-
induced Sup35 dots co-localized with Rnq1 dots in a wild-type strain (Fig 6). In contrast, rela-
tively few oxidant-induced Sup35 dots were found to co-localize with Rnq1 dots in an abp1
mutant. This may explain the reduced frequency of [PSI+] prion formation since Sup35 forms
aggregates in response to oxidative stress conditions, but these aggregates do no efficiently
localize to the IPOD in an abp1 mutant and hence do not form heritable propagons.
Induction of yeast prions by reactive oxygen species
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The IPOD is formed on a perivacuolar site adjacent to the pre-autophagosome (PAS)
where cells initiate autophagy [40, 64]. One possibility is that the PAS may serve to recruit
aggregated prion proteins prior to autophagic turnover. Previous studies may be complicated
by overexpressing Sup35NM-GFP to follow [PSI+] formation which might overwhelm or
impair autophagic flux, and it has been suggested that the IPOD provides a storage site for
excess aggregates [73]. It is known that autophagy protects against de novo formation of [PSI+]
and [PIN+], and conversely, increasing autophagic flux by treating cells with the polyamine
spermidine suppresses prion formation in mutants which normally show a high frequency of
de novo prion formation [23, 74]. Growth under anaerobic conditions in the absence of molec-
ular oxygen prevents Sup35 protein damage and suppressed the high frequency of [PSI+] for-
mation in an autophagy mutant further reinforcing the idea that oxidatively damaged Sup35 is
cleared by autophagy to protect against the structural transitions favouring its conversion to
the propagatable [PSI+] form [23].
Disrupting the cortical actin cytoskeleton not only prevented oxidant-induced [PSI+] for-
mation, but also reduced the spontaneous frequency of de novo [PSI+] formation (Fig 2A).
Similarly, the co-localization of Sup35 and Rnq1 was also disrupted in an abp1 mutant during
non-stress conditions (Fig 6B). Mammalian and fungal prions arise de novo and for example
sporadic forms of CJD account for approximately 80% of all recognised prion disease. How-
ever, the mechanism is poorly understood in molecular terms. It is therefore tempting to spec-
ulate that oxidant-induced prion formation provides a model for these spontaneous events.
Elucidating the underlying mechanism of de novo prion formation following protein oxidation
and how it depends on the balance between clearance of misfolded proteins mediated by
autophagy and the formation of transmissible propagons, will enable a more mechanistic
understanding of de novo prion formation.
Materials and methods
Yeast strains and plasmids
The wild-type yeast strain 74D-694 (MATa ade1-14 ura3-52 leu2-3,112 trp1-289 his3-200)was
used for all experiments. Strains deleted for TSA1 (tsa1::LEU2) and TSA2 (tsa2::kanMX) and
containing Sup35 tagged at its C-terminus with a tandem affinity purification (TAP) tag have
been described previously [37]. Strains deleted for ABP1, CRN1 and PAN1 were constructed in
74D-694 using standard yeast methodology.
The yeast plasmid CUP1-SUP35NM-GFP [URA3] expressing the Sup35NM domain conju-
gated to GFP under the control of the CUP1 promoter has been described previously [75] as
has the yeast plasmid p2018 containing GAL1-SUP35NM-RFP [LEU2] [58]. Rnq1 was visual-
ized using a yeast plasmid containing GAL1-RNQ1-EGFP [URA3] which expresses Rnq1-GFP
under the control of the GAL1 promoter [76]. The yeast plasmid expressing RFP-tagged
Hsp104 (pRP1186, Hsp104-RFP) has been described previously [77]. A thermo-labile allele of
UBC9 fused to GFP (GFP–Ubc9ts) was expressed under the control of the GAL1 galactose-regu-
lated promoter [63]
Growth and stress condition
Strains were grown at 30˚C with shaking at 180 rpm in rich YEPD medium (2% w/v glucose,
2% w/v bactopeptone, 1% w/v yeast extract) or minimal SD (0.67% w/v yeast nitrogen base
without amino acids, 2% w/v glucose) supplemented with appropriate amino acids and bases.
SRaf media contained 2% w/v raffinose and SGal media contained 2% w/v galactose. Media
were solidified by the addition of 2% (w/v) agar. Strains were cured by five rounds of growth
on YEPD agar plates containing 4 mM guanidine hydrochloride (GdnHCl). Where indicated,
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strains were grown in the presence of 100 μM hydrogen peroxide for 20 hours prior to analys-
ing [PSI+] prion formation. Cells were treated with 10 μM latrunculin to disrupt the actin
cytoskeleton.
Analyses of prion formation
The frequency of spontaneous [PSI+] prion formation was scored by growth in the absence of
adenine. Diluted cell cultures were plated onto SD plates lacking adenine (SD-Ade) and incu-
bated for 7–10 days. Colonies which grew on SD-Ade plates were counted and then picked
onto new SD-Ade plates before replica-printing onto SD-Ade and SD-Ade containing 4mM
GdnHCl. Colonies that grew on SD-Ade, but not on SD-Ade with GdnHCl were scored as
[PSI+]. [PSI+] colonies were also scored by visual differentiation of red/white colony formation
on YEPD plates and by the conversion of pink/white [PSI+] colonies to red [psi-] colonies on
YEPD plates containing GdnHCl. For oxidant induced prion assays, cultures were grown in
the presence of 100 μm hydrogen peroxide for 20 hours prior to scoring [PSI+] formation. For
Sup35 overexpression-induced prion assays, cultures were grown in the presence of 50 μM
copper sulphate for 20 hours to induce CUP1-SUP35NM-GFP expression prior to scoring
[PSI+] formation [23]. De novo [PIN+] formation was performed as previously described [37].
Briefly, Sup35NM-GFP was overexpressed in [pin–] [psi–] strains in order to detect cells that
generate [PSI+] de novo. Since [PSI+] formation is dependent on cells being [PIN+] [53], the
rate of [PIN+] formation was estimated based on the number of [PSI+] cells which arise. [PSI+]
and [PIN+] formation was calculated based on the means of at least three independent biologi-
cal repeat experiments.
Microscopy analysis
Rhodamine phalloidin staining of actin was performed as described previously [78].
Sup35 aggregate-formation was visualized using CUP1-SUP35NM-GFP following 50 μM
copper sulphate addition to induce the CUP1 promoter [37]. Sup35 and Rnq1 co-localiza-
tion experiments were conducted using plasmids containing GAL1-SUP35NM-RFP and
GAL1-RNQ1-EGFP. Strains were grown in the presence of absence of 100μM hydrogen
peroxide for 20 hours in SRaf media before switching to SGal media for three hours to
induce the expression of GAL-SUP35NM-RFP and GAL1-RNQ1-EGFP. Visualization of
the aggregation of a non-amyloidogenic protein, Ubc9, was performed using GAL1-GFP–
Ubc9ts. Strains were grown in SRaf media before switching to SGal media for 3 hours to
induce the expression of GAL1-GFP–Ubc9ts. The temperature was shifted to 37˚C for the
final 30 minutes to trigger Ubc9 misfolding.
Cells were washed and immobilised on 10% poly-L-lysine-coated slides. All images were
acquired on a Delta Vision (Applied Precision) restoration microscope using a 100x/NA 1.42
Plan Apo objective and fluorescein isothiocyanate (FITC) and Texas Red band pass filters
from the Sedat filter set (Chroma). The images were collected using a Coolsnap HQ (Photo-
metrics) camera with a Z optical spacing of 0.2μm. Raw images were then deconvolved using
the Softworx software and maximum intensity projections of these deconvolved images are
shown in the results.
Sup35-TAP affinity purification and mass spectrometry
Sup35-TAP affinity purification was performed as described previously [37]. Sup35-interact-
ing proteins were identified in the wild-type and tsa1 tsa2mutant by mass spectrometry in
triplicate for each strain. For protein identification, protein samples were run a short distance
into SDS-PAGE gels and stained using colloidal Coomassie blue (Sigma). Total proteins were
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excised, trypsin digested, and identified using liquid chromatography-mass spectrometry
(LC-MS) performed by the Biomolecular Analysis Core Facility, Faculty of Biology, Medicine
and Health, University of Manchester. Proteins were identified using the Mascot mass finger-
printing programme (www.matrixscience.com) to search the NCBInr and Swissprot databases.
Final datasets for each condition were determined by selecting proteins that were identified in
at least two of the three replicates.
Protein analysis
Protein extracts were electrophoresed under reducing conditions on SDS-PAGE minigels and
electroblotted onto PVDF membrane (Amersham Pharmacia Biotech). Bound antibody was
visualised by chemiluminescence (ECL, Amersham Pharmacia Biotech). Primary antibodies
used were Sup35 [62], Tsa1 [79], Tef1 [80], Abp1 (abcam), Arp3 (Santa Cruz Biotechnology),
Sap190 (affinity-purified polyclonal antibody raised against Sap190 peptides), Act1 (Thermo-
Fisher Scientific) and Pgk1 (ThermoFisher Scientific).
The analysis of Sup35 aggregates by subcellular fractionation was performed essentially as
described previously [62]. Briefly, exponential phase cells (A600*0.5) were collected by centri-
fugation, washed once with distilled water, and resuspended in buffer ST (10mM sodium
phosphate buffer, pH7.5, 250mMNaCl, 2% w/v SDS, 1% w/v Triton X-100, 2mM PMSF).
Cells were broken with glass beads using a Minibead beater (Biospec Scientific, Bartlesville) for
30 s at 4˚C and centrifuged at 3000g for 3 minutes at 4˚C. The supernatant (total) was centri-
fuged at 13000g for 45 minutes at 4˚C to separate the soluble (supernatant) and insoluble (pel-
let) fractions. The soluble and insoluble fractions were resuspended in an equal volume of ST
buffer prior to western blot analysis.
Protein carbonylation was measured by reacting carbonyl groups with 2,4-dinitrophenyl-
hydrazine (DNPH) based on previously described methods [81, 82]. Briefly, exponential phase
cells (A600*0.5) were broken with glass beads in 10% trichloroacetic acid (TCA) using a
Minibead beater. The supernatant was centrifuged at 13000g for 15 mins at 4˚C and the pro-
tein pellet washed with acetone to remove residual TCA. The pellet was dried and resuspended
in 70 μl of 6% (w/v) SDS. 70 μl of 10mM 2,4-dinitrophenyl hydrazine (DNPH) in 10% trifluor-
oacetic acid was added and incubated at room temperature for 20 minutes. 45 μl of 2 M Tris/
30% glycerol was added to the suspension and mixed to neutralize the DNPH reaction.
SDS-PAGE sample buffer was added prior to western blot analysis using rabbit anti::DNPH
(Dako) antibodies to detect carbonylation.
Statistical analysis
Data are presented as mean values ± standard deviation (SD). Statistical analysis for multiple
groups was performed using one-way ANOVA with pair-wise comparisons of sample means
via the Turkey HSD test. An unpaired two-tailed t-test was used for statistical analyses of two
groups of samples. Results were considered statistically significant with a p-value less than
0.05.
Supporting information
S1 Fig. Visualization of overexpression-induced Sup35 aggregates and the cortical actin
cytoskeleton. Fluorescence micrographs are shown for [PIN+][psi-] versions of the wild-type,
abp1, crn1 and pan1 mutant strains containing the Sup35NM-GFP plasmid induced with cop-
per for 24 hours. Rhodamine-phalloidin staining was used to visualize the cortical actin cyto-
skeleton.
(TIF)
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S1 Table. Proteins co-purifying with Sup35 in wild-type and tsa1 tsa2mutant strains.
Sup35-TAP was immunoprecipitated from the wild-type and tsa1 tsa2mutant strains and the
associated proteins identified from three repeat experiments using mass spectrometry. This
resulted in the identification of 63 and 47 proteins which are shown according to whether they
were identified in the wild-type, tsa1 tsa2mutant or both strains.
(DOCX)
S2 Table. Functional categorisation of Sup35-associated proteins. The proteins identified
within each MIPS category classification shown in Fig 1A are listed.
(XLSX)
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